These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28915897)

  • 1. Development of a complex intervention to promote appropriate prescribing and medication intensification in poorly controlled type 2 diabetes mellitus in Irish general practice.
    Murphy ME; Byrne M; Zarabzadeh A; Corrigan D; Fahey T; Smith SM
    Implement Sci; 2017 Sep; 12(1):115. PubMed ID: 28915897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supporting general practitioner-based care for poorly controlled type 2 diabetes mellitus (the DECIDE study): feasibility study and protocol for a pilot cluster randomised controlled trial.
    Murphy ME; Byrne M; Boland F; Corrigan D; Gillespie P; Fahey T; Smith SM
    Pilot Feasibility Stud; 2018; 4():159. PubMed ID: 30345068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supporting care for suboptimally controlled type 2 diabetes mellitus in general practice with a clinical decision support system: a mixed methods pilot cluster randomised trial.
    Murphy ME; McSharry J; Byrne M; Boland F; Corrigan D; Gillespie P; Fahey T; Smith SM
    BMJ Open; 2020 Feb; 10(2):e032594. PubMed ID: 32051304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving medication management in multimorbidity: development of the MultimorbiditY COllaborative Medication Review And DEcision Making (MY COMRADE) intervention using the Behaviour Change Wheel.
    Sinnott C; Mercer SW; Payne RA; Duerden M; Bradley CP; Byrne M
    Implement Sci; 2015 Sep; 10():132. PubMed ID: 26404642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing cardiovascular disease prevention guidelines to translate evidence-based medicine and shared decision making into general practice: theory-based intervention development, qualitative piloting and quantitative feasibility.
    Bonner C; Fajardo MA; Doust J; McCaffery K; Trevena L
    Implement Sci; 2019 Aug; 14(1):86. PubMed ID: 31466526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General practitioner views on the determinants of test ordering: a theory-based qualitative approach to the development of an intervention to improve immunoglobulin requests in primary care.
    Cadogan SL; McHugh SM; Bradley CP; Browne JP; Cahill MR
    Implement Sci; 2016 Jul; 11(1):102. PubMed ID: 27435839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INTEGRA study protocol: primary care intervention in type 2 diabetes patients with poor glycaemic control.
    Molló À; Berenguera A; Rubinat E; Vlacho B; Mata M; Franch J; Bolíbar B; Mauricio D
    BMC Fam Pract; 2019 Feb; 20(1):25. PubMed ID: 30732583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Diabetes care through Examining, Advising, and prescribing (IDEA): protocol for a theory-based cluster randomised controlled trial of a multiple behaviour change intervention aimed at primary healthcare professionals.
    Presseau J; Hawthorne G; Sniehotta FF; Steen N; Francis JJ; Johnston M; Mackintosh J; Grimshaw JM; Kaner E; Elovainio M; Deverill M; Coulthard T; Brown H; Hunter M; Eccles MP
    Implement Sci; 2014 May; 9():61. PubMed ID: 24886606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from the failure of implementing the 'Better Care Better Value' prescribing indicator for renin-angiotensin system drugs in England: a qualitative study of general practitioners' perceptions using behavioural change framework.
    Kurdi A; Elliott RA; Chen LC
    BMJ Open; 2020 Jun; 10(6):e035910. PubMed ID: 32580986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
    Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
    Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of English general practice level data linking medication levels, service activity and demography to levels of glycaemic control being achieved in type 2 diabetes to improve clinical practice and patient outcomes.
    Heald A; Davies M; Stedman M; Livingston M; Lunt M; Fryer A; Gadsby R
    BMJ Open; 2019 Sep; 9(9):e028278. PubMed ID: 31494602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist-led academic detailing intervention in primary care: a mixed methods feasibility study.
    Riordan DO; Hurley E; Sinnott C; Galvin R; Dalton K; Kearney PM; Halpin JD; Byrne S
    Int J Clin Pharm; 2019 Apr; 41(2):574-582. PubMed ID: 30666611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus.
    Reach G; Pechtner V; Gentilella R; Corcos A; Ceriello A
    Diabetes Metab; 2017 Dec; 43(6):501-511. PubMed ID: 28754263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A process evaluation of a cluster randomised trial to reduce potentially inappropriate prescribing in older people in primary care (OPTI-SCRIPT study).
    Clyne B; Cooper JA; Hughes CM; Fahey T; Smith SM;
    Trials; 2016 Aug; 17(1):386. PubMed ID: 27488272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK.
    Boye KS; Stein D; Matza LS; Jordan J; Yu R; Norrbacka K; Hassan SW; García-Pérez LE
    Drugs R D; 2019 Jun; 19(2):213-225. PubMed ID: 31115873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist-led academic detailing improves statin therapy prescribing for Malaysian patients with type 2 diabetes: Quasi-experimental design.
    Elnaem MH; Nik Mohamed MH; Huri HZ
    PLoS One; 2019; 14(9):e0220458. PubMed ID: 31536502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge and prescribing behaviour of Flemish general practitioners regarding novel glucose-lowering medications: Online cross-sectional survey.
    Lecomte J; de Beeck IO; Mamouris P; Mathieu C; Goderis G
    Prim Care Diabetes; 2024 Aug; 18(4):441-447. PubMed ID: 38862313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persons With Diabetes and General/Family Practitioner Perspectives Related to Therapeutic Inertia in Type 2 Diabetes Mellitus Using Qualitative Focus Groups and the Theoretical Domains Framework: Results From the MOTION Study.
    Wrzal PK; Mohseni AA; Fournier C; Goldenberg R; Hollahan D; Jin S; Pedersen SD; Vallis M; Bunko A; Myageri V; Kukaswadia A; Neish CS; Ivers NM
    Can J Diabetes; 2022 Mar; 46(2):171-180. PubMed ID: 35288041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the prescribing behaviour of independent prescriber optometrists: a qualitative study using the Theoretical Domains Framework.
    Spillane D; Courtenay M; Chater A; Family H; Whitaker A; Acton JH
    Ophthalmic Physiol Opt; 2021 Mar; 41(2):301-315. PubMed ID: 33608897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.